# Sevoflurane and Percutaneous Coronary Intervention by Stent

> **NCT02671084** · PHASE4 · TERMINATED · sponsor: **Instituto Dante Pazzanese de Cardiologia** · enrollment: 701 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** sevoflurane

## Key facts

- **NCT ID:** NCT02671084
- **Lead sponsor:** Instituto Dante Pazzanese de Cardiologia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 701 (ACTUAL)
- **Why stopped:** interim analysis suggests futility
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02671084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02671084, "Sevoflurane and Percutaneous Coronary Intervention by Stent". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02671084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*